Neuropsychoimaging Measures as Alternatives to Drug Use Outcomes in Clinical Trials for Addiction

JAMA Psychiatry. 2022 Sep 1;79(9):843-844. doi: 10.1001/jamapsychiatry.2022.1970.

Author

Rita Z Goldstein^{1

2}

Affiliations

¹ Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, New York.
² Department of Neuroscience, Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, New York.

PMID: 35895038
DOI: 10.1001/jamapsychiatry.2022.1970

No abstract available

MeSH terms

Behavior, Addictive*
Clinical Trials as Topic
Humans
Substance-Related Disorders* / therapy